{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T01:13:52Z","timestamp":1789866832972,"version":"4.0.1"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,26]],"date-time":"2025-02-26T00:00:00Z","timestamp":1740528000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,2,26]],"date-time":"2025-02-26T00:00:00Z","timestamp":1740528000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Yunnan Fundamental Research Projects","award":["202201AY070001-140"],"award-info":[{"award-number":["202201AY070001-140"]}]},{"name":"Yunnan Fundamental Research Projects","award":["NO. 202201AT070009"],"award-info":[{"award-number":["NO. 202201AT070009"]}]},{"DOI":"10.13039\/100014717","name":"National Outstanding Youth Science Fund Project of National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["NO. 82360533"],"award-info":[{"award-number":["NO. 82360533"]}],"id":[{"id":"10.13039\/100014717","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Yunnan Province \"Ten Thousand People Plan\"","award":["NO. YNWR-QNBJ-2019-099"],"award-info":[{"award-number":["NO. YNWR-QNBJ-2019-099"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Women's Health"],"DOI":"10.1186\/s12905-025-03574-w","type":"journal-article","created":{"date-parts":[[2025,2,26]],"date-time":"2025-02-26T04:43:37Z","timestamp":1740545017000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["NTRK rearranged spindle cell neoplasm of the uterine cervix: a rare case report and literature review"],"prefix":"10.1186","volume":"25","author":[{"given":"Xiaoxia","family":"Jiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,26]]},"reference":[{"issue":"2","key":"3574_CR1","doi-asserted-by":"publisher","first-page":"70","DOI":"10.32074\/1591-951X-213","volume":"113","author":"M Sbaraglia","year":"2021","unstructured":"Sbaraglia M, Bellan E, Dei Tos AP. The 2020 WHO Classification of Soft Tissue Tumours: news and perspectives. Pathologica. 2021;113(2):70\u201384.","journal-title":"Pathologica"},{"issue":"5892","key":"3574_CR2","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1038\/300539a0","volume":"300","author":"S Pulciani","year":"1982","unstructured":"Pulciani S, Santos E, Lauver AV, Long LK, Aaronson SA, Barbacid M. Oncogenes in solid human tumours. Nature. 1982;300(5892):539\u201342.","journal-title":"Nature."},{"issue":"12","key":"3574_CR3","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1038\/s41571-018-0113-0","volume":"15","author":"E Cocco","year":"2018","unstructured":"Cocco E, Scaltriti M, Drilon A. NTRK fusion-positive cancers and TRK inhibitor therapy. Nat Rev Clin Oncol. 2018;15(12):731\u201347.","journal-title":"Nat Rev Clin Oncol."},{"issue":"1","key":"3574_CR4","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1158\/2159-8290.CD-14-0765","volume":"5","author":"A Vaishnavi","year":"2015","unstructured":"Vaishnavi A, Le AT, Doebele RC. TRKing down an old oncogene in a new era of targeted therapy. Cancer Discov. 2015;5(1):25\u201334.","journal-title":"Cancer Discov."},{"issue":"2","key":"3574_CR5","doi-asserted-by":"publisher","first-page":"e000023","DOI":"10.1136\/esmoopen-2015-000023","volume":"1","author":"A Amatu","year":"2016","unstructured":"Amatu A, Sartore-Bianchi A, Siena S. NTRK gene fusions as novel targets of cancer therapy across multiple tumour types. ESMO Open. 2016;1(2):e000023.","journal-title":"ESMO Open."},{"issue":"6","key":"3574_CR6","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1097\/PAS.0000000000001055","volume":"42","author":"S Chiang","year":"2018","unstructured":"Chiang S, Cotzia P, Hyman DM, Drilon A, Tap WD, Zhang L, Hechtman JF, Frosina D, Jungbluth AA, Murali R, et al. NTRK Fusions Define a Novel Uterine Sarcoma Subtype With Features of Fibrosarcoma. Am J Surg Pathol. 2018;42(6):791\u20138.","journal-title":"Am J Surg Pathol."},{"issue":"7","key":"3574_CR7","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1038\/s41379-018-0184-6","volume":"32","author":"S Croce","year":"2019","unstructured":"Croce S, Hostein I, Longacre TA, Mills AM, P\u00e9rot G, Devouassoux-Shisheboran M, Velasco V, Floquet A, Guyon F, Chakiba C, et al. Uterine and vaginal sarcomas resembling fibrosarcoma: a clinicopathological and molecular analysis of 13 cases showing common NTRK-rearrangements and the description of a COL1A1-PDGFB fusion novel to uterine neoplasms. Mod Pathol. 2019;32(7):1008\u201322.","journal-title":"Mod Pathol."},{"key":"3574_CR8","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.gore.2019.04.006","volume":"28","author":"AE Wells","year":"2019","unstructured":"Wells AE, Mallen AM, Bui MM, Reed DR, Apte SM. NTRK-1 fusion in endocervical fibroblastic malignant peripheral nerve sheath tumor marking eligibility for larotrectinib therapy: a case report. Gynecol Oncol Rep. 2019;28:141\u20134.","journal-title":"Gynecol Oncol Rep."},{"issue":"1","key":"3574_CR9","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1111\/his.14069","volume":"77","author":"JT Rabban","year":"2020","unstructured":"Rabban JT, Devine WP, Sangoi AR, Poder L, Alvarez E, Davis JL, Rudzinski E, Garg K, Bean GR. NTRK fusion cervical sarcoma: a report of three cases, emphasising morphological and immunohistochemical distinction from other uterine sarcomas, including adenosarcoma. Histopathology. 2020;77(1):100\u201311.","journal-title":"Histopathology."},{"key":"3574_CR10","doi-asserted-by":"publisher","first-page":"e00246","DOI":"10.1016\/j.crwh.2020.e00246","volume":"28","author":"W Boyle","year":"2020","unstructured":"Boyle W, Williams A, Sundar S, Yap J, Taniere P, Rehal P, Ganesan R. TMP3-NTRK1 rearranged uterine sarcoma: A case report. Case Rep Womens Health. 2020;28:e00246.","journal-title":"Case Rep Womens Health."},{"issue":"1","key":"3574_CR11","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1038\/s41379-018-0118-3","volume":"32","author":"Z Gatalica","year":"2019","unstructured":"Gatalica Z, Xiu J, Swensen J, Vranic S. Molecular characterization of cancers with NTRK gene fusions. Mod Pathol. 2019;32(1):147\u201353.","journal-title":"Mod Pathol."},{"issue":"4","key":"3574_CR12","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.pathol.2020.02.004","volume":"52","author":"DD Wong","year":"2020","unstructured":"Wong DD, Vargas AC, Bonar F, Maclean F, Kattampallil J, Stewart C, Sulaiman B, Santos L, Gill AJ. NTRK-rearranged mesenchymal tumours: diagnostic challenges, morphological patterns and proposed testing algorithm. Pathology. 2020;52(4):401\u20139.","journal-title":"Pathology."},{"issue":"1","key":"3574_CR13","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1097\/PGP.0000000000000669","volume":"40","author":"A Hodgson","year":"2021","unstructured":"Hodgson A, Pun C, Djordjevic B, Turashvili G. NTRK-rearranged Cervical Sarcoma: Expanding the Clinicopathologic Spectrum. Int J Gynecol Pathol. 2021;40(1):73\u20137.","journal-title":"Int J Gynecol Pathol."},{"issue":"7","key":"3574_CR14","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1177\/1066896921997132","volume":"29","author":"J Munkhdelger","year":"2021","unstructured":"Munkhdelger J, Shimooka T, Koyama Y, Ikeda S, Mikami Y, Fukuoka J, Hori T, Bychkov A. Basaloid Squamous Cell Carcinoma of the Uterine Cervix: Report of a Case With Molecular Analysis. Int J Surg Pathol. 2021;29(7):770\u20134.","journal-title":"Int J Surg Pathol."},{"key":"3574_CR15","doi-asserted-by":"publisher","first-page":"832376","DOI":"10.3389\/fmed.2022.832376","volume":"9","author":"X Dang","year":"2022","unstructured":"Dang X, Xiang T, Zhao C, Tang H, Cui P. EML4-NTRK3 Fusion Cervical Sarcoma: A Case Report and Literature Review. Front Med (Lausanne). 2022;9:832376.","journal-title":"Front Med (Lausanne)."},{"key":"3574_CR16","unstructured":"LI Xiaoqi, WU Xiaohua, LIU Shuai, LU Jing, WU Hongbin, Hao W. Case reports of NTRK-rearranged cervical sarcomas and literature review. Anti-tumor Pharmacy. 2023;13(04):515\u201320."},{"issue":"10","key":"3574_CR17","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1097\/PAS.0000000000001929","volume":"46","author":"DC Costigan","year":"2022","unstructured":"Costigan DC, Nucci MR, Dickson BC, Chang MC, Song S, Sholl LM, Hornick JL, Fletcher CDM, Kolin DL. NTRK -Rearranged Uterine Sarcomas: Clinicopathologic Features of 15 Cases, Literature Review, and Risk Stratification. Am J Surg Pathol. 2022;46(10):1415\u201329.","journal-title":"Am J Surg Pathol."},{"issue":"4","key":"3574_CR18","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1016\/j.ajpath.2013.12.016","volume":"184","author":"S Barthelme\u00df","year":"2014","unstructured":"Barthelme\u00df S, Geddert H, Boltze C, Moskalev EA, Bieg M, Sirbu H, Brors B, Wiemann S, Hartmann A, Agaimy A, et al. Solitary fibrous tumors\/hemangiopericytomas with different variants of the NAB2-STAT6 gene fusion are characterized by specific histomorphology and distinct clinicopathological features. Am J Pathol. 2014;184(4):1209\u201318.","journal-title":"Am J Pathol."},{"issue":"5","key":"3574_CR19","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1097\/PAT.0000000000000122","volume":"46","author":"AL Cheah","year":"2014","unstructured":"Cheah AL, Billings SD, Goldblum JR, Carver P, Tanas MZ, Rubin BP. STAT6 rabbit monoclonal antibody is a robust diagnostic tool for the distinction of solitary fibrous tumour from its mimics. Pathology. 2014;46(5):389\u201395.","journal-title":"Pathology."},{"issue":"1","key":"3574_CR20","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1038\/s41379-019-0324-7","volume":"33","author":"JP Solomon","year":"2020","unstructured":"Solomon JP, Linkov I, Rosado A, Mullaney K, Rosen EY, Frosina D, Jungbluth AA, Zehir A, Benayed R, Drilon A, et al. NTRK fusion detection across multiple assays and 33,997 cases: diagnostic implications and pitfalls. Mod Pathol. 2020;33(1):38\u201346.","journal-title":"Mod Pathol."},{"issue":"9","key":"3574_CR21","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1093\/annonc\/mdz204","volume":"30","author":"C Marchi\u00f2","year":"2019","unstructured":"Marchi\u00f2 C, Scaltriti M, Ladanyi M, Iafrate AJ, Bibeau F, Dietel M, Hechtman JF, Troiani T, L\u00f3pez-Rios F, Douillard JY, et al. ESMO recommendations on the standard methods to detect NTRK fusions in daily practice and clinical research. Ann Oncol. 2019;30(9):1417\u201327.","journal-title":"Ann Oncol."},{"issue":"9","key":"3574_CR22","doi-asserted-by":"publisher","first-page":"2464","DOI":"10.1158\/0008-5472.CAN-16-2479","volume":"77","author":"RJ Hartmaier","year":"2017","unstructured":"Hartmaier RJ, Albacker LA, Chmielecki J, Bailey M, He J, Goldberg ME, Ramkissoon S, Suh J, Elvin JA, Chiacchia S, et al. High-Throughput Genomic Profiling of Adult Solid Tumors Reveals Novel Insights into Cancer Pathogenesis. Cancer Res. 2017;77(9):2464\u201375.","journal-title":"Cancer Res."},{"issue":"8","key":"3574_CR23","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1097\/PAS.0000000000001292","volume":"43","author":"M Michal","year":"2019","unstructured":"Michal M, H\u00e1jkov\u00e1 V, Sk\u00e1lov\u00e1 A, Michal M. STRN-NTRK3-rearranged Mesenchymal Tumor of the Uterus: Expanding the Morphologic Spectrum of Tumors With NTRK Fusions. Am J Surg Pathol. 2019;43(8):1152\u20134.","journal-title":"Am J Surg Pathol."},{"key":"3574_CR24","doi-asserted-by":"crossref","unstructured":"Drilon A. TRK inhibitors in TRK fusion-positive cancers. Ann Oncol. 2019;30(Suppl_8):viii23\u2013viii30.","DOI":"10.1093\/annonc\/mdz282"},{"issue":"23","key":"3574_CR25","doi-asserted-by":"publisher","first-page":"5807","DOI":"10.1158\/1078-0432.CCR-18-1156","volume":"24","author":"ES Kheder","year":"2018","unstructured":"Kheder ES, Hong DS. Emerging Targeted Therapy for Tumors with NTRK Fusion Proteins. Clin Cancer Res. 2018;24(23):5807\u201314.","journal-title":"Clin Cancer Res."},{"issue":"8","key":"3574_CR26","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1056\/NEJMoa1714448","volume":"378","author":"A Drilon","year":"2018","unstructured":"Drilon A, Laetsch TW, Kummar S, DuBois SG, Lassen UN, Demetri GD, Nathenson M, Doebele RC, Farago AF, Pappo AS, et al. Efficacy of Larotrectinib in TRK Fusion-Positive Cancers in Adults and Children. N Engl J Med. 2018;378(8):731\u20139.","journal-title":"N Engl J Med."},{"issue":"2","key":"3574_CR27","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/S1470-2045(19)30691-6","volume":"21","author":"RC Doebele","year":"2020","unstructured":"Doebele RC, Drilon A, Paz-Ares L, Siena S, Shaw AT, Farago AF, Blakely CM, Seto T, Cho BC, Tosi D, et al. Entrectinib in patients with advanced or metastatic NTRK fusion-positive solid tumours: integrated analysis of three phase 1\u20132 trials. Lancet Oncol. 2020;21(2):271\u201382.","journal-title":"Lancet Oncol."},{"key":"3574_CR28","doi-asserted-by":"publisher","first-page":"100845","DOI":"10.1016\/j.gore.2021.100845","volume":"37","author":"EA Goulding","year":"2021","unstructured":"Goulding EA, Morreau P, De Silva M, Watson M, van Vliet C, Leung B, Eva LJ. Case report: NTRK1-rearranged cervical sarcoma with fibrosarcoma like morphology presenting in a 13-year-old managed with a neo-adjuvant TRK-inhibitor and surgical excision. Gynecol Oncol Rep. 2021;37:100845.","journal-title":"Gynecol Oncol Rep."}],"container-title":["BMC Women's Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12905-025-03574-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12905-025-03574-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12905-025-03574-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,26]],"date-time":"2025-02-26T04:43:47Z","timestamp":1740545027000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcwomenshealth.biomedcentral.com\/articles\/10.1186\/s12905-025-03574-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,26]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3574"],"URL":"https:\/\/doi.org\/10.1186\/s12905-025-03574-w","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-3939690\/v1","asserted-by":"object"}]},"ISSN":["1472-6874"],"issn-type":[{"value":"1472-6874","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,26]]},"assertion":[{"value":"8 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Approval was granted by the Ethics Committee of the Yunnan Cancer Hospital (KYLX2022003).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written consent was informed obtained from the patient under the 1975 Declaration of Helsinki.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"88"}}